US 8969409
Treatment for pulmonary hypertension
granted A61KA61K31/513A61K31/522
Quick answer
US patent 8969409 (Treatment for pulmonary hypertension) held by United Therapeutics Corporation expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/513, A61K31/522, A61K31/557, A61K31/5575